We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

This study has been withdrawn prior to enrollment.
(The treatment planned was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01478074
First Posted: November 23, 2011
Last Update Posted: January 3, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
M.D. Anderson Cancer Center
Information provided by (Responsible Party):
Altor BioScience
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: November 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)